MALAISE is the #10 most commonly reported adverse reaction for SACUBITRIL AND VALSARTAN, manufactured by Novartis Pharmaceuticals Corporation. There are 4,419 FDA adverse event reports linking SACUBITRIL AND VALSARTAN to MALAISE. This represents approximately 2.1% of all 209,561 adverse event reports for this drug.
SACUBITRIL AND VALSARTAN has an overall safety score of 85 out of 100. Patients taking SACUBITRIL AND VALSARTAN who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE4,419 of 209,561 reports
MALAISE is a less commonly reported adverse event for SACUBITRIL AND VALSARTAN, but still significant enough to appear in the safety profile.
Other Side Effects of SACUBITRIL AND VALSARTAN
In addition to malaise, the following adverse reactions have been reported for SACUBITRIL AND VALSARTAN:
MALAISE has been reported as an adverse event in 4,419 FDA reports for SACUBITRIL AND VALSARTAN. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with SACUBITRIL AND VALSARTAN?
MALAISE accounts for approximately 2.1% of all adverse event reports for SACUBITRIL AND VALSARTAN, making it a notable side effect.
What should I do if I experience MALAISE while taking SACUBITRIL AND VALSARTAN?
If you experience malaise while taking SACUBITRIL AND VALSARTAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.